SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | 493.36 |
Enterprise Value ($M) | 432.54 |
Book Value ($M) | 222.81 |
Book Value / Share | 2.95 |
Price / Book | 2.21 |
NCAV ($M) | 169.18 |
NCAV / Share | 2.24 |
Price / NCAV | 2.92 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.32 |
Return on Assets (ROA) | -0.28 |
Return on Equity (ROE) | -0.40 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 7.27 |
Current Ratio | 7.27 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 221.70 |
Assets | 275.32 |
Liabilities | 52.52 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -103.92 |
Net Income | -108.68 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -79.13 |
Cash from Investing | 0.00 |
Cash from Financing | 253.20 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Deep Track Capital, LP | 8.19 | -2.50 | |
13G/A | BlackRock, Inc. | 8.30 | 7.17 | |
13G/A | Commodore Capital Lp | 9.90 | 40.17 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
Part Ii – OTHER INFORMATION | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
126,604 | 683,854 | 18.51 | |
146,895 | 773,949 | 18.98 | |
114,129 | 639,408 | 17.85 | |
229,536 | 883,030 | 25.99 | |
(click for more detail) |
Similar Companies | |
---|---|
MGTX – MeiraGTx Holdings plc | MIST – Milestone Pharmaceuticals Inc. |
MLYS – Mineralys Therapeutics, Inc. | MRNA – Moderna, Inc. |
MRSN – Mersana Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io